Clínica Médica
Estudo randomizado | Uma intervenção orientada por atenção plena (mindfulness) pode reduzir a dor crônica e o uso indevido de opioides na atenção primária.
1 Mar, 2022 | 15:10hMindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial – JAMA Internal Medicine (link para o resumo – $ para o texto completo)
Comentário: Mindfulness-Based Intervention Found to Reduce Chronic Pain and Opioid Misuse – Psychiatric News Alert
Comentário no Twitter
A randomized clinical trial showed that #Mindfulness-Oriented Recovery Enhancement delivered in the primary care setting reduces opioid misuse by as much as 46%, while simultaneously reducing chronic pain and emotional distress. https://t.co/eNj42RBCRA @DrEricGarland pic.twitter.com/tBatMT9lkQ
— JAMA Internal Medicine (@JAMAInternalMed) February 28, 2022
Nova diretriz provisória do CDC recomenda um regime de 4 meses de rifapentina-moxifloxacino para tratamento da tuberculose pulmonar não resistente.
28 Fev, 2022 | 13:41hConteúdos relacionados:
Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
WHO Guideline: Screening for Tuberculosis Disease
New WHO Recommendations to Prevent Tuberculosis
CDC Guidelines for the Treatment of Latent Tuberculosis Infection
Guideline: Treatment of Drug-Resistant Tuberculosis
The Lancet Commission: Management of Multidrug-resistant and Incurable Tuberculosis
Regimens to Treat Multidrug-resistant Tuberculosis: Past, Present and Future Perspectives
Guidelines for the Management of TB in Adults Living with HIV
Comentário no Twitter
Clinicians: @CDC_TB released interim guidance on a new regimen to treat #TB disease. Learn more about the 4-month regimen containing rifapentine, moxifloxacin, isoniazid, and pyrazinamide for people with drug-susceptible pulmonary TB disease in the U.S.: https://t.co/eOcR34tYJu pic.twitter.com/EFGMwAwN7c
— MMWR (@CDCMMWR) February 25, 2022
Diretrizes ESCMID COVID-19: testes diagnósticos para SARS-CoV-2.
28 Fev, 2022 | 13:39hESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2 – Clinical Microbiology and Infection
CDC emite nova diretriz muito aguardada sobre quando usar máscaras.
28 Fev, 2022 | 13:38hCDC issues long-awaited new guidance on when to wear masks – STAT
Ver também: As mask mandates fade, experts say use of masks likely will not – STAT
Diretriz | Plasmaférese e dosagem de glicocorticoides para pacientes com vasculite associada a ANCA.
28 Fev, 2022 | 13:35h
Comentário no Twitter
New rapid recommendation makes a weak recommendation against plasma exchange in patients with low risk of end stage kidney disease, and a weak recommendation in favour of plasma exchange in patients with moderate-high risk of ESKD https://t.co/PeEjSuRIxI #BMJInfographic pic.twitter.com/YR55t6XYhS
— The BMJ (@bmj_latest) February 25, 2022
Metanálise sugere que há baixo risco de hemorragia intracraniana tardia (depois de uma tomografia computadorizada negativa de cabeça) após traumatismo craniano contuso de baixa energia durante o uso de anticoagulantes orais diretos.
28 Fev, 2022 | 13:31hAnálise prospectiva de participantes do Biobank do Reino Unido | Risco de câncer em vegetarianos, consumidores de peixe e indivíduos que ingerem pouca carne.
25 Fev, 2022 | 14:18hComentários:
Expert reaction to study looking at eating meat and risk of cancer – Science Media Centre
Low-meat and meat-free diets associated with lower overall cancer risk – Biomed Central
Comentário no Twitter
Study suggests being #vegetarian may be associated w/lower risk of #cancer
⬇️risk of #colorectalcancer in low meat 🥩 eaters consistent w/evidence of impact of meat
⬇️risk of postmenopausal #breastcancer in #vegetarian 🌱women may be explained by🔽BMIhttps://t.co/1uQfEFgoRT pic.twitter.com/VHhh9NbFSL
— Gil Morgan (@weoncologists) February 25, 2022
Revisão sistemática | Plano de alta hospitalar.
25 Fev, 2022 | 14:17hDischarge planning from hospital – Cochrane Library
Resumo: Discharge planning from hospital – Cochrane Library
Comentário no Twitter
"When people leave hospital with a personalised discharge plan [vs. standard discharge care], there is probably a small reduction in length of stay & they are probably slightly less likely to be re-admitted to hospital".
The latest @CochraneEPOC evidence: https://t.co/EUF6RTRlbp pic.twitter.com/Y0JYQ3qcpD
— Cochrane UK (@CochraneUK) February 24, 2022
Revisão narrativa | Pré-habilitação, recuperação precoce após cirurgia ou ambas?
25 Fev, 2022 | 14:14hVer também: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines (algumas diretrizes são de acesso gratuito)
Opinião | Uma abordagem “mais, mais, mais” do rastreamento de câncer é equivocada e prejudicial.
25 Fev, 2022 | 14:07hA ‘more, more, more’ approach to cancer screening is misleading and harmful – STAT